Ameriprise’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.3M | Buy |
460,195
+293,895
| +177% | +$12M | ﹤0.01% | 1557 |
|
|
2025
Q4 | $6.75M | Sell |
166,300
-4,369
| -3% | -$190K | ﹤0.01% | 2217 |
|
|
2025
Q3 | $8.03M | Sell |
170,669
-2,242
| -1% | -$116K | ﹤0.01% | 2077 |
|
|
2025
Q2 | $9.01M | Sell |
172,911
-7,607
| -4% | -$417K | ﹤0.01% | 1899 |
|
|
2025
Q1 | $10.9M | Sell |
180,518
-8,865
| -5% | -$571K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $13M | Sell |
189,383
-4,101
| -2% | -$286K | ﹤0.01% | 1618 |
|
|
2024
Q3 | $13.9M | Sell |
193,484
-6,323
| -3% | -$446K | ﹤0.01% | 1543 |
|
|
2024
Q2 | $13.9M | Sell |
199,807
-563,321
| -74% | -$41.1M | ﹤0.01% | 1502 |
|
|
2024
Q1 | $61.1M | Sell |
763,128
-195,549
| -20% | -$17.4M | 0.02% | 714 |
|
|
2023
Q4 | $105M | Sell |
958,677
-8,494
| -0.9% | -$878K | 0.03% | 502 |
|
|
2023
Q3 | $97.5M | Sell |
967,171
-86,907
| -8% | -$9.99M | 0.03% | 506 |
|
|
2023
Q2 | $143M | Sell |
1,054,078
-296,785
| -22% | -$36.2M | 0.04% | 393 |
|
|
2023
Q1 | $140M | Buy |
1,350,863
+99,568
| +8% | +$9.63M | 0.05% | 389 |
|
|
2022
Q4 | $111M | Sell |
1,251,295
-123,339
| -9% | -$10.2M | 0.04% | 445 |
|
|
2022
Q3 | $110M | Buy |
1,374,634
+60,175
| +5% | +$5.68M | 0.04% | 429 |
|
|
2022
Q2 | $126M | Buy |
1,314,459
+83,711
| +7% | +$10M | 0.04% | 403 |
|
|
2022
Q1 | $183M | Buy |
1,230,748
+74,006
| +6% | +$10.3M | 0.05% | 358 |
|
|
2021
Q4 | $164M | Buy |
1,156,742
+135,342
| +13% | +$19.2M | 0.05% | 409 |
|
|
2021
Q3 | $134M | Buy |
1,021,400
+123,953
| +14% | +$16.2M | 0.04% | 430 |
|
|
2021
Q2 | $123M | Buy |
897,447
+142,010
| +19% | +$19.4M | 0.04% | 462 |
|
|
2021
Q1 | $98.7M | Buy |
755,437
+329,938
| +78% | +$39.7M | 0.03% | 513 |
|
|
2020
Q4 | $47.7M | Buy |
425,499
+17,559
| +4% | +$1.66M | 0.02% | 759 |
|
|
2020
Q3 | $32.1M | Sell |
407,940
-39,467
| -9% | -$3.22M | 0.01% | 830 |
|
|
2020
Q2 | $32.2M | Buy |
447,407
+237,375
| +113% | +$16.5M | 0.01% | 803 |
|
|
2020
Q1 | $12M | Buy |
210,032
+245
| +0.1% | +$22.6K | 0.01% | 1256 |
|
|
2019
Q4 | $23.5M | Buy |
209,787
+2,925
| +1% | +$312K | 0.01% | 1065 |
|
|
2019
Q3 | $19.9M | Sell |
206,862
-1,056
| -0.5% | -$99.1K | 0.01% | 1145 |
|
|
2019
Q2 | $17.8M | Sell |
207,918
-31,875
| -13% | -$2.62M | 0.01% | 1262 |
|
|
2019
Q1 | $19.9M | Sell |
239,793
-3,074
| -1% | -$223K | 0.01% | 1147 |
|
|
2018
Q4 | $15.6M | Buy |
242,867
+16,682
| +7% | +$1.14M | 0.01% | 1226 |
|
|
2018
Q3 | $17.9M | Buy |
226,185
+12,871
| +6% | +$996K | 0.01% | 1397 |
|
|
2018
Q2 | $15.6M | Buy |
213,314
+52,051
| +32% | +$3.54M | 0.01% | 1372 |
|
|
2018
Q1 | $10.2M | Buy |
161,263
+8,860
| +6% | +$529K | ﹤0.01% | 1644 |
|
|
2017
Q4 | $7.77M | Sell |
152,403
-2,709
| -2% | -$141K | ﹤0.01% | 1806 |
|
|
2017
Q3 | $8.14M | Buy |
155,112
+13,514
| +10% | +$678K | ﹤0.01% | 1741 |
|
|
2017
Q2 | $7.21M | Buy |
141,598
+10,730
| +8% | +$531K | ﹤0.01% | 1805 |
|
|
2017
Q1 | $5.81M | Buy |
130,868
+5,670
| +5% | +$244K | ﹤0.01% | 1916 |
|
|
2016
Q4 | $5.53M | Buy |
125,198
+1,860
| +2% | +$79K | ﹤0.01% | 1964 |
|
|
2016
Q3 | $4.94M | Sell |
123,338
-2,715
| -2% | -$115K | ﹤0.01% | 1999 |
|
|
2016
Q2 | $6.02M | Buy |
126,053
+4,321
| +4% | +$183K | ﹤0.01% | 1794 |
|
|
2016
Q1 | $5.11M | Buy |
121,732
+2,612
| +2% | +$103K | ﹤0.01% | 1925 |
|
|
2015
Q4 | $5.25M | Sell |
119,120
-2,722
| -2% | -$118K | ﹤0.01% | 1987 |
|
|
2015
Q3 | $5.82M | Sell |
121,842
-9,789
| -7% | -$537K | ﹤0.01% | 1908 |
|
|
2015
Q2 | $7.67M | Buy |
131,631
+2,563
| +2% | +$138K | ﹤0.01% | 1810 |
|
|
2015
Q1 | $6.52M | Buy |
129,068
+4,201
| +3% | +$206K | ﹤0.01% | 1924 |
|
|
2014
Q4 | $5.62M | Buy |
124,867
+3,201
| +3% | +$134K | ﹤0.01% | 1979 |
|
|
2014
Q3 | $4.48M | Sell |
121,666
-281,140
| -70% | -$11.2M | ﹤0.01% | 2093 |
|
|
2014
Q2 | $17.8M | Sell |
402,806
-444,884
| -52% | -$20.2M | 0.01% | 1097 |
|
|
2014
Q1 | $36.8M | Sell |
847,690
-422,536
| -33% | -$18.8M | 0.02% | 665 |
|
|
2013
Q4 | $54M | Buy |
1,270,226
+113,016
| +10% | +$4.29M | 0.03% | 502 |
|
|
2013
Q3 | $39.3M | Buy |
1,157,210
+89,160
| +8% | +$2.91M | 0.03% | 632 |
|
|
2013
Q2 | $33.4M | Buy |
+1,068,050
| New | +$34.7M | 0.02% | 698 |
|
Other funds holding CNMD
VPM
VCM
CB
Ameriprise's CNMD Position: Q1 2026 in Review
Ameriprise increased its CONMED (CNMD) stake by 177% in Q1 2026, buying an estimated $12M and bringing the position to 460,195 shares worth $16.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1557.
Ameriprise first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $183M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Ameriprise held 460,195 shares of CONMED worth $16.3M as of Q1 2026.
- Ameriprise bought 293,895 CONMED shares in Q1 2026, an estimated $12M.
- CONMED made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #1557 holding.
- Ameriprise first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's CONMED position peaked at $183M in Q1 2022.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.